EW Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 22:00):

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally...

Stats
Tagesvolumen	4.96M
Durchschnittsvolumen	4.02M
Marktkapitalisierung	51.97B
EPS	$0 ( 2024-04-25 )
Nächstes Ertragsdatum	( $0.700 ) 2024-07-24
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	37.58
ATR14	$0.101 (0.12%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-09	Lippis Daniel J.	Buy	857	Common Stock
2024-04-09	Lippis Daniel J.	Sell	857	Common Stock
2024-04-09	Lippis Daniel J.	Sell	857	Employee Stock Option (Right to Acquire)
2024-04-08	Lemercier Jean-luc M	Buy	14 400	Common Stock
2024-04-08	Lemercier Jean-luc M	Sell	107	Common Stock

INSIDER POWER
-32.00
Last 99 transactions
Buy: 337 983 \| Sell: 687 280

Volumen Korrelation

Lang: 0.60 (weak)

Kurz: -0.79 (moderate negative)

Signal:(48.119) Neutral

Edwards Lifesciences Corp Korrelation

10 Am meisten positiv korreliert
CVII	0.829
ERJ	0.822
PNTM	0.82
CXAC	0.814
GIA	0.811
YSAC	0.808
KOF	0.805
IBDO	0.805
ULST	0.805
IRRX	0.804

10 Am meisten negativ korreliert
NXQ	-0.842
NIC	-0.826
DBMF	-0.821
EQNR	-0.814
HBB	-0.814
CVS	-0.813
EVA	-0.806
FUL	-0.801
LDOS	-0.801

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Edwards Lifesciences Corp Korrelation - Währung/Rohstoff

0.55
( weak )

0.66
( moderate )

0.00
( neutral )

0.58
( weak )

0.20
( neutral )

0.17
( neutral )

Edwards Lifesciences Corp Finanzdaten

Annual	2023
Umsatz:	$6.00B
Bruttogewinn:	$4.63B (77.02 %)
EPS:	$2.31

FY	2023
Umsatz:	$6.00B
Bruttogewinn:	$4.63B (77.02 %)
EPS:	$2.31

FY	2022
Umsatz:	$5.38B
Bruttogewinn:	$4.30B (79.93 %)
EPS:	$2.46

FY	2021
Umsatz:	$5.23B
Bruttogewinn:	$3.98B (76.13 %)
EPS:	$2.41

Financial Reports:

No articles found.

Edwards Lifesciences Corp

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.